Income StatementBalance SheetCash FlowSegments
Equinix, Inc. logo

Equinix, Inc. Cash Flow Statement

Operating, investing, and financing cash movements

Equinix, Inc. generated $3.8B in operating cash flow over the trailing twelve months. After $4.8B in capital expenditures, free cash flow was -$998.0M. Free cash flow decreased 3.8% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$3.8BNet Cash From Investing (TTM)-$7.0BNet Cash From Financing (TTM)$3.0BCapital Expenditures (TTM)$4.8BDepreciation And Amortization Cf (TTM)$2.0BNet Change In Cash (TTM)-$1.5B
Latest FilingQ1 2026
Report Date2026-04-29
Market Cap$106.49B
P/E Ratio74.89
ROE10.09%

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other non-cash income (expense)-$17.0M$1.0M-$28.0M—-$12.0M$3.0M
Other non-cash income (expense)-$17.0M$1.0M-$28.0M—-$12.0M$3.0M
Change in accounts payable$193.0M-$149.0M——$74.0M-$62.0M
Change in accounts receivable-$180.0M$133.0M$36.0M$11.0M—$106.0M
Change in income taxes payable/receivable—-$2.0M-$43.0M-$46.0M—-$7.0M
Other working capital changes$231.0M-$155.0M$128.0M-$57.0M$97.0M$180.0M
Depreciation and amortization$502.0M$480.0M$400.0M$533.0M$551.0M$544.0M
Other Non-Cash Income (Expense)-$17.0M$1.0M-$28.0M—-$12.0M$3.0M
Other Non-cash Income (Expense)-$17.0M$1.0M-$28.0M—-$12.0M$3.0M
Other Non-cash Income (Expense)-$17.0M$1.0M-$28.0M—-$12.0M$3.0M
Net cash from operating activities$981.0M$809.0M$944.0M$1.0B$1.1B$717.0M
Net income$0.0$343.0M$367.0M$374.0M$264.0M$415.0M
Other non-cash income (expense)-$17.0M$1.0M-$28.0M—-$12.0M$3.0M
Asset write-downs$233.0M$0.0$1.0M$4.0M$63.0M$2.0M
Gain (Loss) on Disposition of Assets$0.0$0.0$0.0$1.0M$0.0$20.0M
Operating lease liabilities-$51.0M-$39.0M-$32.0M-$42.0M-$43.0M-$35.0M
Increase (Decrease) In Operating Lease Right-Of-Use Assets-$33.0M-$42.0M-$37.0M-$43.0M-$39.0M-$41.0M
Other Noncash Income (Expense)-$17.0M$1.0M-$28.0M—-$12.0M$3.0M
Other Non-cash Income and Expense-$17.0M$1.0M-$28.0M—-$12.0M$3.0M
Other Non-Cash Adjustments-$17.0M$1.0M-$28.0M—-$12.0M$3.0M
Other Non-Cash Income and Expense-$17.0M$1.0M-$28.0M—-$12.0M$3.0M
Stock-based compensation$114.0M$113.0M$127.0M$130.0M$128.0M$128.0M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Dividends paid$413.0M$468.0M$460.0M$467.0M$461.0M$519.0M
Finance Lease, Principal Payments$39.0M$32.0M$40.0M$39.0M$44.0M$41.0M
Proceeds From Issuance Of Senior Long Term Debt$1.2B$370.0M$1.7B$500.0M$1.7B$1.5B
Proceeds from exercises of stock options and other stock issuances—$50.0M—$45.0M—$49.0M
Other, net-$10.0M-$4.0M$10.0M-$16.0M-$16.0M$42.0M
Repayments of Senior Debt$1.0B$300.0M$300.0M$300.0M$300.0M—
Finance lease prepayments$39.0M$32.0M$40.0M$39.0M$44.0M$41.0M
Payment of Deferred Purchase Consideration-$10.0M-$4.0M$10.0M-$16.0M-$16.0M$42.0M
Noncontrolling interest transactions and other-$10.0M-$4.0M$10.0M-$16.0M-$16.0M$42.0M
Net cash from financing activities$478.0M$15.0M$1.2B—$1.2B$349.0M
Noncontrolling Interests Activity and Other-$10.0M-$4.0M$10.0M-$16.0M-$16.0M$42.0M
Proceeds from issuance of common stock$697.0M$99.0M———$0.0

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Payments for Derivative Instruments (Investing)-$83.0M-$32.0M-$18.0M-$45.0M-$9.0M$3.0M
Proceeds from Derivative Instrument Investing Activities-$83.0M-$32.0M-$18.0M-$45.0M-$9.0M$3.0M
Payments for (Proceeds from) Derivative Instruments, Investing-$83.0M-$32.0M-$18.0M-$45.0M-$9.0M$3.0M
Payments for (Proceeds from) Derivative Instrument, Investing Activities-$83.0M-$32.0M-$18.0M-$45.0M-$9.0M$3.0M
Payments to Acquire Equity Method Investments$33.0M$43.0M$5.0M$6.0M$6.0M$146.0M
Payments to Acquire Loans Receivable$65.0M——$17.0M$7.0M—
Payments to Acquire Other Property, Plant, and Equipment$987.0M$750.0M$989.0M$1.1B$1.4B$1.3B
Payments To Acquire Real Estate$50.0M$17.0M$82.0M$292.0M$603.0M$123.0M
Payments to Acquire Short-Term Investments$70.0M$190.0M$605.0M$297.0M$875.0M$784.0M
Proceeds from disposition of marketable securities and other investments$0.0$0.0$450.0M$320.0M$235.0M$595.0M
Proceeds from disposals of property, plant and equipment—$0.0$0.0$0.0$0.0$258.0M
Net cash from investing activities-$1.1B-$964.0M-$1.4B-$1.4B-$2.7B-$1.5B
Dividend Received from Consumer Healthcare JV$11.0M$4.0M$0.0$13.0M$42.0M$0.0
Investing Cash Flows from Derivatives-$83.0M-$32.0M-$18.0M-$45.0M-$9.0M$3.0M
Payments for (Proceeds from) Derivative Instruments, Investing-$83.0M-$32.0M-$18.0M-$45.0M-$9.0M$3.0M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$0.0$59.0M-$45.0M-$122.0M-$292.0M-$539.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$42.0M$20.0M$33.0M——-$6.0M
Net increase (decrease) in cash$306.0M-$120.0M$728.0M-$1.5B-$341.0M-$399.0M
Repayments of Other Debt—$0.0———$674.0M

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income taxes paid$46.3M$51.8M$51.8M$51.8M$51.8M—
Cash paid for interest, net of amounts capitalized$121.5M$112.0M$112.0M$112.0M$112.0M—